Cochlear Limited (CHEOF)
USD 176.25
(0.0%)
USD 176.25
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -269.9 Million AUD | 23.69% |
| 2023 | -353.7 Million AUD | 5.78% |
| 2022 | -375.4 Million AUD | -8.72% |
| 2021 | -345.3 Million AUD | -347.53% |
| 2020 | 139.5 Million AUD | 35.44% |
| 2019 | 103 Million AUD | 19.49% |
| 2018 | 86.2 Million AUD | -33.38% |
| 2017 | 129.38 Million AUD | 9.81% |
| 2016 | 117.82 Million AUD | -16.14% |
| 2015 | 140.5 Million AUD | -22.5% |
| 2014 | 181.28 Million AUD | 53.92% |
| 2013 | 117.78 Million AUD | 4285.5% |
| 2012 | -2.81 Million AUD | 70.01% |
| 2011 | -9.38 Million AUD | -108.24% |
| 2010 | 113.93 Million AUD | 4.95% |
| 2009 | 108.56 Million AUD | -18.55% |
| 2008 | 133.29 Million AUD | 15.4% |
| 2007 | 115.5 Million AUD | 6.0% |
| 2006 | 108.96 Million AUD | 11.86% |
| 2005 | 97.41 Million AUD | 294.52% |
| 2004 | -50.07 Million AUD | -73.37% |
| 2003 | -28.88 Million AUD | -310.65% |
| 2002 | 13.71 Million AUD | 164.27% |
| 2001 | -21.33 Million AUD | -2.6% |
| 2000 | -20.79 Million AUD | 31.53% |
| 1999 | -30.36 Million AUD | -83.94% |
| 1998 | -16.51 Million AUD | -55.14% |
| 1997 | -10.64 Million AUD | 12.54% |
| 1996 | -12.16 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q4 | -269.9 Million AUD | 3.09% |
| 2024 FY | -269.9 Million AUD | 23.69% |
| 2024 Q2 | -278.5 Million AUD | 21.26% |
| 2023 FY | -353.7 Million AUD | 5.78% |
| 2023 Q4 | -353.7 Million AUD | -30.37% |
| 2023 Q2 | -271.3 Million AUD | 27.73% |
| 2022 Q4 | -375.4 Million AUD | -30.8% |
| 2022 Q2 | -287 Million AUD | 16.88% |
| 2022 FY | -375.4 Million AUD | -8.72% |
| 2021 FY | -345.3 Million AUD | -347.53% |
| 2021 Q4 | -345.3 Million AUD | -35.62% |
| 2021 Q2 | -254.6 Million AUD | -282.51% |
| 2020 Q2 | 333 Million AUD | 223.3% |
| 2020 FY | 139.5 Million AUD | 35.44% |
| 2020 Q4 | 139.5 Million AUD | -58.11% |
| 2019 Q2 | 72.7 Million AUD | -15.66% |
| 2019 Q4 | 103 Million AUD | 41.68% |
| 2019 FY | 103 Million AUD | 19.49% |
| 2018 FY | 86.2 Million AUD | -33.38% |
| 2018 Q4 | 86.2 Million AUD | -37.13% |
| 2018 Q2 | 137.1 Million AUD | 5.97% |
| 2017 Q4 | 129.38 Million AUD | 38.34% |
| 2017 Q2 | 93.52 Million AUD | -20.62% |
| 2017 FY | 129.38 Million AUD | 9.81% |
| 2016 Q2 | 132.86 Million AUD | -5.44% |
| 2016 FY | 117.82 Million AUD | -16.14% |
| 2016 Q4 | 117.82 Million AUD | -11.32% |
| 2015 Q4 | 140.5 Million AUD | -18.13% |
| 2015 FY | 140.5 Million AUD | -22.5% |
| 2015 Q2 | 171.6 Million AUD | -5.34% |
| 2014 Q4 | 181.28 Million AUD | 8.99% |
| 2014 FY | 181.28 Million AUD | 53.92% |
| 2014 Q2 | 166.32 Million AUD | 41.22% |
| 2013 Q4 | 117.78 Million AUD | 0.0% |
| 2013 FY | 117.78 Million AUD | 4285.5% |
| 2012 FY | -2.81 Million AUD | 70.01% |
| 2012 Q4 | -2.81 Million AUD | 0.0% |
| 2011 Q4 | -9.38 Million AUD | 0.0% |
| 2011 FY | -9.38 Million AUD | -108.24% |
| 2010 Q4 | 113.93 Million AUD | 0.0% |
| 2010 FY | 113.93 Million AUD | 4.95% |
| 2009 Q4 | 108.56 Million AUD | 0.0% |
| 2009 FY | 108.56 Million AUD | -18.55% |
| 2008 FY | 133.29 Million AUD | 15.4% |
| 2008 Q4 | 133.29 Million AUD | 0.0% |
| 2007 FY | 115.5 Million AUD | 6.0% |
| 2007 Q4 | 115.5 Million AUD | 0.0% |
| 2006 Q4 | 108.96 Million AUD | 0.0% |
| 2006 FY | 108.96 Million AUD | 11.86% |
| 2005 FY | 97.41 Million AUD | 294.52% |
| 2005 Q4 | 97.41 Million AUD | 0.0% |
| 2004 Q4 | -50.07 Million AUD | 0.0% |
| 2004 FY | -50.07 Million AUD | -73.37% |
| 2003 Q4 | -28.88 Million AUD | 0.0% |
| 2003 FY | -28.88 Million AUD | -310.65% |
| 2002 FY | 13.71 Million AUD | 164.27% |
| 2002 Q4 | 13.71 Million AUD | 0.0% |
| 2001 Q4 | -21.33 Million AUD | 0.0% |
| 2001 FY | -21.33 Million AUD | -2.6% |
| 2000 FY | -20.79 Million AUD | 31.53% |
| 2000 Q4 | -20.79 Million AUD | 0.0% |
| 1999 FY | -30.36 Million AUD | -83.94% |
| 1999 Q4 | -30.36 Million AUD | 0.0% |
| 1998 Q4 | -16.51 Million AUD | 0.0% |
| 1998 FY | -16.51 Million AUD | -55.14% |
| 1997 FY | -10.64 Million AUD | 12.54% |
| 1997 Q4 | -10.64 Million AUD | 0.0% |
| 1996 FY | -12.16 Million AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Manhattan Scientifics, Inc. | -7000.00 USD | -3855614.286% |
| Össur hf. | 395.08 Million USD | 168.315% |
| QHSLab, Inc. | 1.72 Million USD | 15701.427% |
| Wellstar International, Inc. | 51.36 Million USD | 625.435% |
| Össur hf. | 395.08 Million USD | 168.315% |
| Bionovate Technologies Corp | - USD | Infinity% |
| Escalon Medical Corp. | 315.68 Thousand USD | 85596.348% |
| Aurora Spine Corporation | 1.9 Million USD | 14248.261% |
| BrainsWay Ltd. | -10.32 Million USD | -2515.31% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| AVITA Medical, Inc. | -26.23 Million USD | -928.911% |
| CVR Medical Corp. | - USD | Infinity% |
| Hamilton Thorne Ltd. | 18.12 Million USD | 1589.018% |
| BioElectronics Corporation | 14.82 Million USD | 1920.383% |
| Vivos Inc. | -1.59 Million USD | -16850.462% |
| Kelyniam Global, Inc. | 487.33 Thousand USD | 55483.075% |
| Zecotek Photonics Inc. | 2.76 Million USD | 9870.313% |
| REMSleep Holdings, Inc. | -540.98 Thousand USD | -49790.385% |
| EKF Diagnostics Holdings plc | -4.61 Million USD | -5745.571% |
| Avitar, Inc. | 5.17 Million USD | 5319.335% |
| Nanomix Corporation | 11.38 Million USD | 2469.798% |
| Theraclion SA | -5.86 Million EUR | -4502.24% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | 3.98 Million USD | 6872.078% |
| NewCardio, Inc. | 2.41 Million USD | 11275.863% |
| Positron Corporation | 1.68 Million USD | 16099.953% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | 1.61 Million USD | 16855.212% |
| Lombard Medical, Inc. | 11.49 Million USD | 2447.977% |
| ALR Technologies Inc. | 19.14 Million USD | 1509.529% |
| Stratec SE | 119.12 Million USD | 326.57% |
| Vycor Medical, Inc. | 1.05 Million USD | 25732.576% |
| Heart Tronics, Inc. | 54.99 Thousand USD | 490871.888% |
| Nu-Med Plus, Inc. | 93.19 Thousand USD | 289710.919% |
| MicroPort Scientific Corporation | 673.58 Million USD | 140.069% |
| VMS Rehab Systems, Inc. | 133.52 USD | 202142101.198% |
| Guided Therapeutics, Inc. | 1.46 Million USD | 18498.104% |
| Ingen Technologies, Inc. | 630.91 Thousand USD | 42878.867% |
| CYduct Diagnostics, Inc. | 640.19 Thousand USD | 42258.898% |
| Odyssey Group International, Inc. | 2.1 Million USD | 12904.851% |
| SANUWAVE Health, Inc. | 30.14 Million USD | 995.28% |
| IR-Med Inc. | -606 Thousand USD | -44437.954% |
| Perimeter Medical Imaging AI, Inc. | -13.78 Million USD | -1857.601% |
| United American Healthcare Corporation | -9.32 Million USD | -2793.749% |
| Polarean Imaging plc | -5.94 Million USD | -4438.777% |
| ECGI Holdings, Inc. | 3.17 Million USD | 8610.858% |
| Capital Group Holdings, Inc. | -3508.00 USD | -7693742.645% |
| ADM Tronics Unlimited, Inc. | 262.61 Thousand USD | 102872.849% |
| Medical Supply International USA, Inc. | 216.6 Thousand USD | 124702.969% |
| Rapid Therapeutic Science Laboratories, Inc. | 4.2 Million USD | 6511.805% |
| Nexeon MedSystems Inc. | 3.33 Million USD | 8202.071% |
| SS Innovations International, Inc. | 1.18 Million USD | 22869.742% |
| Urologix, Inc. | 4.61 Million USD | 5948.321% |
| Qualis Innovations, Inc. | 6671.00 USD | 4045970.184% |
| Smith & Nephew plc | 2.77 Billion USD | 109.715% |
| NIOX Group Plc | -23.93 Million USD | -1027.76% |
| Fuse Medical, Inc. | 1.75 Million USD | 15474.581% |
| Broncus Holding Corporation | -81.42 Million USD | -231.471% |
| Brain Scientific Inc. | 2.11 Million USD | 12856.579% |
| Pressure BioSciences, Inc. | 22.67 Million USD | 1290.188% |
| Health Logic Interactive Inc. | 39.55 Thousand USD | 682406.545% |